Kyowa Kirin

POTELIGEO

  1. Home
  2.  / 
  3. J Code
  4.  / POTELIGEO – J9204

Manufacturer:

Kyowa Kirin

Name:

POTELIGEO

HCPCS Code Descriptor:

Injection, mogamulizumab-kpkc, 1 mg

Category:

J Code

HCPCS:

J9204

NDC(s):

42747-0761-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

POTELIGEO is an Oncology drug manufactured by Kyowa Kirin and administered via the Intravenous route of administration. The J Code: J9204 is aligned to the drug POTELIGEO.

Access Pricing and More By Registering

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj mogamulizumab-kpkc, 1 mg

Billing and Coding Guide:

https://www.poteligeohcp.com/assets/files/POTELIGEO-Billing-and-Coding-Guide.pdf

Patient Assistance:

https://www.kyowakirincares.com/poteligeo-patients/

POTELIGEO - J9204